Oculis Holding AG (OCS) Intangibles (2021 - 2026)
Oculis Holding AG (OCS) recorded quarterly Intangibles of $17.0 million in Q1 2026, up 2.06% quarter-over-quarter from $16.6 million in Q4 2025, and up 14.81% on a YoY basis from $14.8 million in Q1 2025.
Oculis Holding AG (OCS) Intangibles (2021 - 2026) Analysis & Trends
Oculis Holding AG's Intangibles history runs 6 years deep, the most recent figure standing at $17.0 million for Q1 2026.
- In Q1 2026, Intangibles rose 14.81% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $17.0 million (up 14.81% YoY), while the FY2025 annual figure was $16.6 million, up 9.61% from the prior year.
- Intangibles was $17.0 million for Q1 2026 at Oculis Holding AG, up from $16.6 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $17.0 million in Q1 2026 to a low of -$1.3 million in Q2 2025.
- Historically, Intangibles has averaged $13.4 million across 5 years, with a median of $14.0 million in 2024.
- The sharpest annual moves came in 2022 and 2025: Intangibles surged 34.29% in 2022, then slumped 109.73% in 2025.
- A 5-year view of Intangibles shows it stood at $12.7 million in 2022, then gained by 8.61% to $13.8 million in 2023, then advanced by 10.27% to $15.2 million in 2024, then increased by 9.61% to $16.6 million in 2025, then gained by 2.06% to $17.0 million in 2026.
- The last three Intangibles figures came in at $17.0 million (Q1 2026), $16.6 million (Q4 2025), and $16.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 7.73 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | 16.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.97 Mn |
| Dec 31, 2025 | 16.63 Mn |
| Sep 30, 2025 | 16.62 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Mar 31, 2025 | 14.78 Mn |
| Dec 31, 2024 | 15.17 Mn |
| Sep 30, 2024 | 14.09 Mn |
| Jun 30, 2024 | 13.50 Mn |
| Mar 31, 2024 | 13.98 Mn |
| Dec 31, 2023 | 13.76 Mn |
| Sep 30, 2023 | 13.82 Mn |
| Jun 30, 2023 | 13.58 Mn |
| Dec 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 9.44 Mn |